TEK and neoplasm: The blockade of the interaction between Ang-2 and its cognate receptor TIE2 determines regression of the tumor vasculature and inhibition of tumor progression in the RIP1-Tag2 mouse model of pancreatic endocrine cancerogenesis (50).